Clinical Trial Update: A Study of Obexelimab in Patients With Systemic Lupus Erythematosus [Phase 2]

View source ↗

Summary

This clinical trial update notes that Obexelimab is being studied in a Phase 2 trial for systemic lupus erythematosus and is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Systemic Lupus Erythematosus

Drugs mentioned

• Obexelimab (obexelimab)

Snippet

Sponsor: Zenas BioPharma (USA), LLC | Conditions: Systemic Lupus Erythematosus | Phase 2 | Status: RECRUITING